FDA Inspection 1292250 — Ailex Pharmaceuticals LLC
The FDA completed an inspection of Ailex Pharmaceuticals LLC on Nov 6, 2025 in Lenexa, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 6, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lenexa, KS (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)